Login
Toggle navigation
Videos
Categories
Trending
Alan Beasley, CEO, Hydroponics Company Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
OAR Resources: Advancing Australian Projects and Global Ventures
00:10:00
Deciding on a Financial Advisor: Key Times to Seek Professional Guidance - Dave Zoller | Certified Financial Planner, Streamline Financial
00:10:00
Richard Carleton CEO of the Canadian Securities Exchange
00:10:00
CompoSecure CEO Jon Wilk on Global Expansion and Fintech Growth | Jon Wilk - CEO of CompoSecure
00:10:00
venture capital who has adapted to a new career path, depending on the direction|Amy Saper,Partner,Accel
00:10:00
SiTime CEO Rajesh Vashist states that 85% of their customers are single-source.
00:10:00
District Center's Smart Building Platform Transforms Workplace with Advanced Technology
00:10:00
John Wood, CEO of Telos, discusses the origins and benefits of the partnership with AWS Public Sector.|John Wood, CEO of Telos Corporation
00:10:00
Jeff Guldner, Chairman, President, and CEO of Pinnacle West Capital Corporation, discusses insights at NYSE Floor Talk.
00:10:00
A VC fund focused on investing in AI, fintech, software infrastructure|Andrew Romans, Partner, 7BC Venture Capital
00:10:00
Alstom CEO Discusses Bombardier Acquisition on "Good Morning Business | Henri Poupart Lafarge - CEO of Alstom
00:10:00
Assay TV Interview with Eric Allard, CEO of Tantalex Lithium Resources